Keyphrases
Systematic Meta-analysis
100%
Meta-analysis of Randomized Controlled Trials
100%
Tacrolimus
100%
Active Rheumatoid Arthritis
100%
Intolerant
50%
Disease-modifying Antirheumatic Drugs (DMARDs)
50%
Multidrug-resistant
37%
Risk Ratio
37%
Adverse Events
25%
Confidence Interval
25%
Randomized Controlled Trial
25%
Efficacy Outcomes
25%
Safety Outcomes
25%
ACR50
25%
Follow-up Interval
12%
Response Rate
12%
Rheumatoid Arthritis
12%
Rheumatoid Arthritis Patients
12%
Weighted Mean Difference
12%
Methotrexate
12%
Primary Safety
12%
Clinical Benefit
12%
MEDLINE
12%
Cochrane
12%
Treatment Efficacy
12%
Treatment Safety
12%
Standardized Mean Difference
12%
Manual Search
12%
ACR20
12%
American College of Rheumatology
12%
Pharmacology, Toxicology and Pharmaceutical Science
Rheumatoid Arthritis
100%
Randomized Controlled Trial
100%
Tacrolimus
100%
Inflammatory Arthritis
100%
Disease Modifying Antirheumatic Drug
50%
Adverse Event
25%
Combination Therapy
12%
Methotrexate
12%
Immunology and Microbiology
Inflammatory Arthritis
100%
Tacrolimus
100%
Disease-Modifying Antirheumatic Drug
50%
Methotrexate
12%
Medline
12%
Cochrane Library
12%
Biochemistry, Genetics and Molecular Biology
Randomized Controlled Trial
100%
Medline
25%
Cochrane Library
25%
Methotrexate
25%